Search alternatives:
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 1,301 - 1,320 results of 47,816 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 16 ((nn decrease) OR (a decrease)) ))', query time: 0.82s Refine Results
  1. 1301
    Fig 3 -

    Fig 3 - by Pedro A. R. Vanzele (17655589)

    Published 2023
    Save to List
    Saved in:
  2. 1302
    Fig 1 -

    Fig 1 - by Pedro A. R. Vanzele (17655589)

    Published 2023
    Save to List
    Saved in:
  3. 1303
    Shared and exclusive Amplicon Sequence Variants (ASVs) before and after the oral diet implementation.

    Shared and exclusive Amplicon Sequence Variants (ASVs) before and after the oral diet implementation. by Pedro A. R. Vanzele (17655589)

    Published 2023
    Save to List
    Saved in:
  4. 1304
    S1 Fig -

    S1 Fig - by Pedro A. R. Vanzele (17655589)

    Published 2023
    Save to List
    Saved in:
  5. 1305
    Shared and exclusive Amplicon Sequence Variants (ASVs) between the postpartum weeks (first, third, and fourth week).

    Shared and exclusive Amplicon Sequence Variants (ASVs) between the postpartum weeks (first, third, and fourth week). by Pedro A. R. Vanzele (17655589)

    Published 2023
    Save to List
    Saved in:
  6. 1306
    Descriptive data of newborns enrolled in the study (n = 23).

    Descriptive data of newborns enrolled in the study (n = 23). by Pedro A. R. Vanzele (17655589)

    Published 2023
    Save to List
    Saved in:
  7. 1307
    Fig 4 -

    Fig 4 - by Pedro A. R. Vanzele (17655589)

    Published 2023
    Save to List
    Saved in:
  8. 1308
    Heatmap of the Amplicon Sequencing Variants (ASVs) abundance (y-axis) significantly associated with the postpartum weeks (first, third and fourth week) by oral diet status (no/yes) (x-axis) using generalized linear models (Maaslin) and filtered by ASVs with a minimum prevalence of 25%.

    Heatmap of the Amplicon Sequencing Variants (ASVs) abundance (y-axis) significantly associated with the postpartum weeks (first, third and fourth week) by oral diet status (no/yes)... by Pedro A. R. Vanzele (17655589)

    Published 2023
    Save to List
    Saved in:
  9. 1309
    Image_6_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif

    Image_6_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif by Ozair Abawi (8816267)

    Published 2022
    “…In 9 children with pseudohypoparathyroidism type 1a, mean REE% was similar (100.4 ± 5.1). Across all patients, mREE was decreased in 60 (21%) patients and elevated in 69 (24%) patients. …”
    Save to List
    Saved in:
  10. 1310
    Image_3_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif

    Image_3_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif by Ozair Abawi (8816267)

    Published 2022
    “…In 9 children with pseudohypoparathyroidism type 1a, mean REE% was similar (100.4 ± 5.1). Across all patients, mREE was decreased in 60 (21%) patients and elevated in 69 (24%) patients. …”
    Save to List
    Saved in:
  11. 1311
    Image_8_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif

    Image_8_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif by Ozair Abawi (8816267)

    Published 2022
    “…In 9 children with pseudohypoparathyroidism type 1a, mean REE% was similar (100.4 ± 5.1). Across all patients, mREE was decreased in 60 (21%) patients and elevated in 69 (24%) patients. …”
    Save to List
    Saved in:
  12. 1312
    Image_7_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif

    Image_7_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif by Ozair Abawi (8816267)

    Published 2022
    “…In 9 children with pseudohypoparathyroidism type 1a, mean REE% was similar (100.4 ± 5.1). Across all patients, mREE was decreased in 60 (21%) patients and elevated in 69 (24%) patients. …”
    Save to List
    Saved in:
  13. 1313
    Image_4_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif

    Image_4_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif by Ozair Abawi (8816267)

    Published 2022
    “…In 9 children with pseudohypoparathyroidism type 1a, mean REE% was similar (100.4 ± 5.1). Across all patients, mREE was decreased in 60 (21%) patients and elevated in 69 (24%) patients. …”
    Save to List
    Saved in:
  14. 1314
    Image_5_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif

    Image_5_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif by Ozair Abawi (8816267)

    Published 2022
    “…In 9 children with pseudohypoparathyroidism type 1a, mean REE% was similar (100.4 ± 5.1). Across all patients, mREE was decreased in 60 (21%) patients and elevated in 69 (24%) patients. …”
    Save to List
    Saved in:
  15. 1315
    Image_1_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif

    Image_1_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif by Ozair Abawi (8816267)

    Published 2022
    “…In 9 children with pseudohypoparathyroidism type 1a, mean REE% was similar (100.4 ± 5.1). Across all patients, mREE was decreased in 60 (21%) patients and elevated in 69 (24%) patients. …”
    Save to List
    Saved in:
  16. 1316
    DataSheet_1_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.docx

    DataSheet_1_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.docx by Ozair Abawi (8816267)

    Published 2022
    “…In 9 children with pseudohypoparathyroidism type 1a, mean REE% was similar (100.4 ± 5.1). Across all patients, mREE was decreased in 60 (21%) patients and elevated in 69 (24%) patients. …”
    Save to List
    Saved in:
  17. 1317
    Image_2_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif

    Image_2_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif by Ozair Abawi (8816267)

    Published 2022
    “…In 9 children with pseudohypoparathyroidism type 1a, mean REE% was similar (100.4 ± 5.1). Across all patients, mREE was decreased in 60 (21%) patients and elevated in 69 (24%) patients. …”
    Save to List
    Saved in:
  18. 1318
    Colocalization of TGN with EdU-labeled pseudogenome is not affected by DCT siRNA or XXI treatment of HaCaTs at 16hpi.

    Colocalization of TGN with EdU-labeled pseudogenome is not affected by DCT siRNA or XXI treatment of HaCaTs at 16hpi. by Pınar Aksoy (3663211)

    Published 2017
    Save to List
    Saved in:
  19. 1319
    Tendency chart of monthly FVC mean.

    Tendency chart of monthly FVC mean. by Yichuan Zhang (2888345)

    Published 2024
    “…The dynamic changes of monthly FVC at regional scale were described through the dynamic changes in the monthly FVC mean and in the FVC areas at various scales, and the dynamic changes in the monthly FVC were analyzed using the coefficient of variation and curve change trends. …”
    Save to List
    Saved in:
  20. 1320
    List of excluded articles.

    List of excluded articles. by Yasmine Makhlouf (17409866)

    Published 2025
    Save to List
    Saved in:

Search Tools: